# Dermolab Pharma Ltd. – FDA Inspection, Oct 13, 2023

Source: https://www.keypedia.com/records/fda_inspections/dermolab-pharma-ltd/673d4a87-0ca4-4516-9cd0-0d9dc48f3610
Source feed: FDA_Inspections

> FDA inspection 1220238 of Dermolab Pharma Ltd., October 13, 2023. Classification: Voluntary Action Indicated (VAI). 8 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1220238
- Company Name: Dermolab Pharma Ltd.
- Inspection Date: 2023-10-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 8

## Related Documents

- [FDA Inspection 1017775 - 2017-06-22](https://www.keypedia.com/records/fda_inspections/dermolab-pharma-ltd/44b42bb0-8a87-43c3-9f20-017b4514b468)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jessica-s-estriplet/b7152ec3-6e1b-45aa-840e-7147f357aea2)

Company: https://www.keypedia.com/companies/dermolab-pharma-ltd/7225f963-3084-4281-b5da-e046668f2136

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c